272 filings
Page 5 of 14
CORRESP
zfqklgs e4ls
29 Jul 21
Correspondence with SEC
12:00am
UPLOAD
8g3sad4
28 Jul 21
Letter from SEC
12:00am
8-K
a7v9f9cbjp4 a5qvyh
15 Jul 21
Other Events
6:45am
8-K
8ulbjcp
17 Jun 21
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
7:35am
8-K
93y5nz uf
11 Jun 21
Submission of Matters to a Vote of Security Holders
5:02pm
8-K
jz5ilf jxg
13 May 21
Synlogic Reports First Quarter Financial Results and Provides Business Update
6:46am
8-K
xa6nmptf4izjv05eyvf
5 May 21
Entry into a Material Definitive Agreement
4:06pm
DEFA14A
i1uklbd
27 Apr 21
Additional proxy soliciting materials
4:30pm
424B5
fqk 69wr4c
19 Apr 21
Prospectus supplement for primary offering
4:06pm
8-K
iv58gbthqb4tzbk
16 Apr 21
Synlogic Announces Proposed Public Offering of Common Stock
8:35am
424B5
bdpl599g3
15 Apr 21
Prospectus supplement for primary offering
4:21pm
8-K
tj4kvfhwqj v1
14 Apr 21
Synlogic Presents Data from SYNB1891 Phase 1 Trial at American Association for Cancer Research (AACR) Annual Meeting
12:00am
S-8
paxx4i9evd2 hcd
25 Mar 21
Registration of securities for employees
8:33am
S-8
j9tqmiveytu3s
25 Mar 21
Registration of securities for employees
8:30am
8-K
h7uewm1n7tqt9oumy 96
25 Mar 21
Synlogic Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
8:04am
8-K
t2bq10k
24 Mar 21
Synlogic Announces SYNB8802 Will Advance to Phase 1B Proof of Concept Study After Proof of Mechanism Demonstrated in Dietary Hyperoxaluria
4:59pm